Low Protein Diet, Gut Microbiome and Chronic Kidney Disease
Primary Purpose
Chronic Kidney Diseases
Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
low protein diet
Sponsored by
About this trial
This is an interventional prevention trial for Chronic Kidney Diseases
Eligibility Criteria
Inclusion Criteria:
- . Patients aged 30-90 years with diagnosis of CKD (defined as abovementioned).
- . Sign the inform consent and agree to participate in this study.
- . Compliant to low protein diet (defined as protein intake <0.8 g/Kg/day) for 4 weeks assessed by 24h urine urea estimates, before enrollment
Exclusion Criteria:
- . History of any malignancy, liver cirrhosis, intestinal operation, irritable bowel syndrome, cardiovascular disease (defined as myocardial infarction, documented Q wave on EKG, unstable angina, coronary artery disease with stenosis > 75%, congestive heart failure with Ejection Fraction < 50% and cerebrovascular disease) in the past 3 months.
- . History of or infection disease requiring admission in the past 3 months or, concomitant antibiotics use.
- . Concomitant use of probiotics or prebiotics.
- . Pregnancy.
- . Renal transplant recipients.
Sites / Locations
- Chang Gung Memorial Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Experimental
Active Comparator
Arm Label
normal controls
CKD_Low protein diet
CKD_normal protein diet
Arm Description
subjects with normal renal function
CKD patient with low protein diet (<0.8g/kg/BW)
CKD patient with normal protein diet
Outcomes
Primary Outcome Measures
change of gut microbiota
change of relative abundance of microbes
change of host metabolite concentration
change of concentration of serum metabolomic profile
change of renal function
serum creatinine, estimated glomerular filtration rate or urine total protein
Secondary Outcome Measures
Full Information
NCT ID
NCT05019599
First Posted
January 19, 2021
Last Updated
August 20, 2021
Sponsor
Chang Gung Memorial Hospital
Collaborators
Ministry of Science and Technology, Taiwan
1. Study Identification
Unique Protocol Identification Number
NCT05019599
Brief Title
Low Protein Diet, Gut Microbiome and Chronic Kidney Disease
Official Title
Exploring the Role of Low Protein Diet on the Gut Microbiome, Related Metabolites and Renal Function in Chronic Kidney Disease
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
August 1, 2019 (Actual)
Primary Completion Date
July 31, 2020 (Actual)
Study Completion Date
October 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chang Gung Memorial Hospital
Collaborators
Ministry of Science and Technology, Taiwan
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Chronic kidney disease (CKD) is a worldwide public health dilemma because of close association with multiple comorbidities, demanding high cardiovascular events, mortality and expensive medical cost. Novel and effective therapeutic measures remain urgently needed to reduce burden and impact of disease. Advanced renal failure can profoundly alter the biochemical milieu of the gastrointestinal tract leading to a leak gut. Application of 16s rRNA gene analysis identified an increase of Clostridia, Actinobacteria, and Gammaproteobacteria in hemodialysis patients and decrease of Bifidobacterium and lactobacillus in peritoneal patients. This altered microbiome consequently affect production of indole or phenol derived uremic toxins leading to renal damage. Our preliminary results indicated reduced number and diversity of intestinal microbes CKD patients compared to normal. Different dietary nutrients can affect the gut microbiome and derive several deleterious metabolites leading to metabolic disarrangement. Clinically, low-protein diet should be prescribe to renal patients to preserve renal function and high fat content are usually recommended to avoid caloric malnutrition to dietary restriction. The changes of diet-microbiome-metabolite interaction are large unknown with this dietary manipulation. The aims of this study is to determine the renal progression-associated gene and taxonomic alterations bymetagenome-wide association studies and the functional characterization of gut microbiome in CKD patients receiving different low-protein or high-fat diets. The results of the study will provide insight on the exact role of dietary manipulation in CKD patients from gut-renal cross talk.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Kidney Diseases
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
nutritional intervention with low protein diet (< 0.8 G protein/kg body weight/day)
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
normal controls
Arm Type
No Intervention
Arm Description
subjects with normal renal function
Arm Title
CKD_Low protein diet
Arm Type
Experimental
Arm Description
CKD patient with low protein diet (<0.8g/kg/BW)
Arm Title
CKD_normal protein diet
Arm Type
Active Comparator
Arm Description
CKD patient with normal protein diet
Intervention Type
Other
Intervention Name(s)
low protein diet
Intervention Description
Low protein diet (<0.8g/kg/BW/day)
Primary Outcome Measure Information:
Title
change of gut microbiota
Description
change of relative abundance of microbes
Time Frame
3 months
Title
change of host metabolite concentration
Description
change of concentration of serum metabolomic profile
Time Frame
3 months
Title
change of renal function
Description
serum creatinine, estimated glomerular filtration rate or urine total protein
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
. Patients aged 30-90 years with diagnosis of CKD (defined as abovementioned).
. Sign the inform consent and agree to participate in this study.
. Compliant to low protein diet (defined as protein intake <0.8 g/Kg/day) for 4 weeks assessed by 24h urine urea estimates, before enrollment
Exclusion Criteria:
. History of any malignancy, liver cirrhosis, intestinal operation, irritable bowel syndrome, cardiovascular disease (defined as myocardial infarction, documented Q wave on EKG, unstable angina, coronary artery disease with stenosis > 75%, congestive heart failure with Ejection Fraction < 50% and cerebrovascular disease) in the past 3 months.
. History of or infection disease requiring admission in the past 3 months or, concomitant antibiotics use.
. Concomitant use of probiotics or prebiotics.
. Pregnancy.
. Renal transplant recipients.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
I Wen Wu
Organizational Affiliation
Chang Gung Memorial Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chang Gung Memorial Hospital
City
Keelung
ZIP/Postal Code
204
Country
Taiwan
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32932711
Citation
Wu IW, Lee CC, Hsu HJ, Sun CY, Chen YC, Yang KJ, Yang CW, Chung WH, Lai HC, Chang LC, Su SC. Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction. Nutrients. 2020 Sep 12;12(9):2799. doi: 10.3390/nu12092799.
Results Reference
result
Links:
URL
https://res.mdpi.com/d_attachment/nutrients/nutrients-11-03006/article_deploy/nutrients-11-03006.pdf
Description
Related Info
Learn more about this trial
Low Protein Diet, Gut Microbiome and Chronic Kidney Disease
We'll reach out to this number within 24 hrs